Evidence map›Paper›PMID 23480827›Full record

ArticleBiochemistry2013

Variable contributions of basic residues forming an APC exosite in the binding and inactivation of factor VIIIa.

Masahiro Takeyama, Jennifer M Wintermute, Chandrashekhara Manithody, Alireza R Rezaie, Philip J Fay

Abstract read
In one paragraph

Article in Biochemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 6 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Masahiro TakeyamaDepartment of Biochemistry and Biophysics, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Jennifer M Wintermute
Chandrashekhara Manithody
Alireza R Rezaie
Philip J Fay
University of Rochester · USSaint Louis University · US

Funding

Protease Activated Receptor Signaling by Coagulation ProteasesR01HL101917 · NHLBI · SAINT LOUIS UNIVERSITY · PI Lijun Xia · 2010 to 2026
$6.6M
Serpin Regulation of Coagulation ProteasesR01HL062565 · NHLBI · SAINT LOUIS UNIVERSITY · PI REZAIE, ALIREZA R. · 1999 to 2020
$6.2M
STRUCTURE AND REGULATION OF HUMAN FACTOR VIIIR01HL038199 · NHLBI · UNIVERSITY OF ROCHESTER · PI WAKABAYASHI, HIRONAO · 1988 to 2013
$4.7M
Factor Vllla interactions in the intrinsic factor XaseR01HL076213 · NHLBI · UNIVERSITY OF ROCHESTER · PI FAY, PHILIP J. · 2004 to 2011
$3.2M
NHLBI NIH HHS HL101917NHLBI NIH HHS HL38199NHLBI NIH HHS HL62565NHLBI NIH HHS HL76213NHLBI NIH HHS R01 HL038199NHLBI NIH HHS R01 HL062565NHLBI NIH HHS R01 HL076213NHLBI NIH HHS R01 HL101917
6 · The paper itself

Abstract

Basic residues contained in the 39-, 60-, and 70-80-loops of activated protein C (APC) comprise an exosite that contributes to the binding and subsequent proteolytic inactivation of factor (F) VIIIa. Surface plasmon resonance (SPR) showed that WT APC bound to FVIII light chain (LC) and the FVIIIa A1/A3C1C2 dimer with equivalent affinity (Kd = 525 and 546 nM, respectively). These affinity values may reflect binding interactions to the acidic residue-rich a1 and a3 segments adjacent to A1 domain in the A1/A3C1C2 and A3 domain in LC, respectively. Results from SPR, using a panel of APC exosite variants where basic residues were mutated, in binding to immobilized FVIIIa A1/A3C1C2 or LC indicated ~4-10-fold increases in the Kd values relative to WT for several of the variants including Lys39Ala, Lys37-Lys38-Lys39/Pro-Gln-Glu, and Arg67Ala. On the other hand, a number of APC variants including Lys38Ala, Lys62Ala, and Lys78Ala showed little if any change in binding affinity to the FVIII substrates. FXa generation assays and Western blotting, used to monitor rates of FVIIIa inactivation and proteolysis at the primary cleavage site in the cofactor (Arg(336)), respectively, showed marked rate reductions relative to WT for the Lys39Ala, Lys37-Lys38-Lys39/Pro-Gln-Glu, Arg67Ala, and Arg74Ala variants. Furthermore, kinetic analysis monitoring FVIIIa inactivation by APC variants at varying FVIIIa substrate concentration showed ~2.6-4.4-fold increases in Km values relative to WT. These results show a variable contribution of basic residues comprising the APC exosite, with significant contributions from Lys39, Arg67, and Arg74 to forming a FVIIIa-interactive site.

Indexed as

Amino Acid SubstitutionBinding SitesFactor VIIIaGene ExpressionHEK293 CellsHumansModels, MolecularProtein BindingProtein CProtein ConformationProtein MultimerizationProtein Structure, TertiaryProtein SubunitsRecombinant ProteinsFactor VIIIaProtein CProtein SubunitsRecombinant Proteins

Identifiers

PMID23480827
PMCPMC3645000
OpenAlexW1974703244

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.